Literature DB >> 15871859

Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.

E Diakoumopoulou1, N Tentolouris, E Kirlaki, D Perrea, E Kitsou, M Psallas, D Doulgerakis, N Katsilambros.   

Abstract

BACKGROUND AND AIM: Hyperhomocysteinemia is a major and independent risk factor for atherothrombotic vascular disease. It may be promoted by genetic factors, nutritional deficiencies of the vitamin cofactors required for homocysteine metabolism, and other modifiable factors. This cross-sectional study investigated the effect of dietary habits and lifestyle on plasma total homocysteine (tHcy) levels in patients with type 2 diabetes in a Mediterranean population. METHODS AND
RESULTS: A total of 126 diabetic and 76 healthy subjects were interviewed using a food-frequency questionnaire. Information consisted of dietary and smoking habits, coffee and alcohol consumption and physical activity recording, during the month prior to enrollment. Measurements included blood pressure, body mass index (BMI), waist-to-hip ratio (WHR), plasma tHcy, folate, vitamin B12, lipids, HbA(1c), creatinine, uric acid, and glomerular filtration rate (GFR). Plasma tHcy levels were not different between diabetic and control subjects (11.49+/-3.68 vs 12.67+/-3.79 micromol/l respectively, P = 0.40). Diabetic subjects had significantly higher plasma folate levels and consumed more fish, fruit and vegetables, in comparison with controls. Controls consumed more red meat, coffee, and alcohol. Multivariate analysis in diabetic subjects, after controlling for age, sex, systolic blood pressure, duration of diabetes, GFR, plasma uric acid levels, and the amount of the weekly consumption of fruit and vegetables, demonstrated that age, GFR and the weekly amount of fruit and vegetable consumption were independently associated with plasma tHcy concentrations [regression coefficient (B) = 0.11, SE (B) = 0.03, P = 0.001, B = -0.07, SE (B) = 0.01, P < 0.0001, and B = -0.05, SE (B) = 0.02, P = 0.04, respectively]. The weekly amount of coffee, alcohol and red meat consumption, and physical activity level were not related with plasma tHcy levels in either study group.
CONCLUSIONS: 1) Plasma tHcy levels were not different in the diabetic group as compared to the control group. 2) In patients with type 2 diabetes age, GFR and the consumption of fruit and vegetables were strong and independent determinants of plasma tHcy levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871859     DOI: 10.1016/j.numecd.2004.01.001

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  12 in total

1.  Factors associated with serum total homocysteine level in type 2 diabetes.

Authors:  Yumi Masuda; Akira Kubo; Akatsuki Kokaze; Masao Yoshida; Nobuki Fukuhara; Yutaka Takashima
Journal:  Environ Health Prev Med       Date:  2008-03-29       Impact factor: 3.674

2.  High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts.

Authors:  A Solini; E Santini; M Nannipieri; E Ferrannini
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

3.  Hepatocyte nuclear factor (HNF)-4alpha-driven epigenetic silencing of the human PED gene.

Authors:  P Ungaro; R Teperino; P Mirra; M Longo; M Ciccarelli; G A Raciti; C Nigro; C Miele; P Formisano; F Beguinot
Journal:  Diabetologia       Date:  2010-04-16       Impact factor: 10.122

4.  Serum homocysteine is related to food intake in adolescents: the Child and Adolescent Trial for Cardiovascular Health.

Authors:  Pamela L Lutsey; Lyn M Steffen; Henry A Feldman; Deanna H Hoelscher; Larry S Webber; Russell V Luepker; Leslie A Lytle; Michelle Zive; Stavroula K Osganian
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

5.  Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.

Authors:  Zhongjian Cheng; Xiaohua Jiang; Meghana Pansuria; Pu Fang; Jietang Mai; Karthik Mallilankaraman; Rajesh Kumar Gandhirajan; Satoru Eguchi; Rosario Scalia; Muniswamy Madesh; Xiaofeng Yang; Hong Wang
Journal:  Diabetes       Date:  2014-10-28       Impact factor: 9.461

Review 6.  The role of metformin on vitamin B12 deficiency: a meta-analysis review.

Authors:  Mitra Niafar; Faizi Hai; Jahan Porhomayon; Nader Djalal Nader
Journal:  Intern Emerg Med       Date:  2014-12-13       Impact factor: 3.397

7.  Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study.

Authors:  Dai-Yin Lu; Chin-Chou Huang; Po-Hsun Huang; Chia-Min Chung; Shing-Jong Lin; Jaw-Wen Chen; Wan-Leong Chan; Hsin-Bang Leu
Journal:  BMC Cardiovasc Disord       Date:  2014-12-15       Impact factor: 2.298

8.  Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction.

Authors:  Daniel E Platt; Essa Hariri; Pascale Salameh; Mahmoud Merhi; Nada Sabbah; Mariana Helou; Francis Mouzaya; Rita Nemer; Yasser Al-Sarraj; Hatem El-Shanti; Antoine B Abchee; Pierre A Zalloua
Journal:  Diabetol Metab Syndr       Date:  2017-03-21       Impact factor: 3.320

9.  Differences in traditional and non-traditional risk factors with special reference to nutritional factors in patients with coronary artery disease with or without diabetes mellitus.

Authors:  Namita P Mahalle; M K Garg; Mohan V Kulkarni; Sadanand S Naik
Journal:  Indian J Endocrinol Metab       Date:  2013-09

10.  Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes.

Authors:  Antonysunil Adaikalakoteswari; Ramamurthy Jayashri; Nithya Sukumar; Hema Venkataraman; Rajendra Pradeepa; Kuppan Gokulakrishnan; Ranjit Mohan Anjana; Philip G McTernan; Gyanendra Tripathi; Vinod Patel; Sudhesh Kumar; Viswanathan Mohan; Ponnusamy Saravanan
Journal:  Cardiovasc Diabetol       Date:  2014-09-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.